PharmaCyte Biotech, Inc.

PMCB · NASDAQ
Analyze with AI
4/30/2025
4/30/2024
4/30/2023
4/30/2022
Assets
Cash & Equivalents$15,172$50,180$68,040$85,401
Short-Term Investments$366$0$0$0
Receivables$3,696$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$3,141$260$108$94
Total Curr. Assets$22,375$50,440$68,148$85,495
Property Plant & Equip (Net)$0$0$0$0
Goodwill$0$0$0$0
Intangibles$1,549$1,549$3,549$3,549
Long-Term Investments$22,474$7,907$1,572$1,572
Tax Assets$0$0$0$0
Other NC Assets$8,770$8$8$8
Total NC Assets$32,793$9,464$5,129$5,129
Other Assets$0$0$0$0
Total Assets$55,168$59,904$73,277$90,624
Liabilities
Payables$399$389$128$205
Short-Term Debt$0$0$0$0
Tax Payable$0$340$58$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$2,515$6,692$400$499
Total Curr. Liab.$2,914$7,421$587$704
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$363$12,968$0$0
Total NC Liab.$363$12,968$0$0
Other Liabilities$0$0$0-$205
Cap. Leases$0$0$0$0
Total Liabilities$3,277$20,389$587$704
Equity
Pref Stock$0$11,867$0$0
Common Stock$2$2$2$2
Retained Earnings-$84,969-$115,625-$115,959-$111,649
AOCI-$24-$24-$23-$16
Other Equity$136,882$143,294$188,670$201,582
Total Equity$51,891$39,515$72,690$89,920
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$55,168$59,904$73,277$90,624
Net Debt-$15,172-$50,180-$68,040-$85,401
PharmaCyte Biotech, Inc. (PMCB) Financial Statements & Key Stats | AlphaPilot